May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
WDR36: A Potential Modifier Gene Altering Glaucoma Severity in a Huge French-Canadian Myocilin Family
Author Affiliations & Notes
  • V. Raymond
    Ocular Genetics & Genomics, Laval University Hospital (CHUL) Research Center, Québec City, Quebec, Canada
  • K. Lebel
    Ocular Genetics & Genomics, Laval University Hospital (CHUL) Research Center, Québec City, Quebec, Canada
  • P. Belleau
    Ocular Genetics & Genomics, Laval University Hospital (CHUL) Research Center, Québec City, Quebec, Canada
  • R. Arseneault
    Ocular Genetics & Genomics, Laval University Hospital (CHUL) Research Center, Québec City, Quebec, Canada
  • J.-L. Anctil
    Ophthalmology, Laval University Eye Hospital, Québec City, Quebec, Canada
  • G. Côté
    Ophthalmology, Laval University Eye Hospital, Québec City, Quebec, Canada
  • M. Amyot
    Ophthalmology, Université de Montréal, Montréal, Quebec, Canada
  • The Québec Glaucoma Network
    Ocular Genetics & Genomics, Laval University Hospital (CHUL) Research Center, Québec City, Quebec, Canada
  • Footnotes
    Commercial Relationships  V. Raymond, None; K. Lebel, None; P. Belleau, None; R. Arseneault, None; J. Anctil, None; G. Côté, None; M. Amyot, None.
  • Footnotes
    Support  CIHR Grant MOP-64219; FRSQ Vision Research Network, Fondation des Maladies de l'Oeil
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5115. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V. Raymond, K. Lebel, P. Belleau, R. Arseneault, J.-L. Anctil, G. Côté, M. Amyot, The Québec Glaucoma Network; WDR36: A Potential Modifier Gene Altering Glaucoma Severity in a Huge French-Canadian Myocilin Family. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5115. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Primary open-angle glaucoma (POAG) is a complex disorder. While myocilin(MYOC) mutations account for about 4 % of cases, contribution of WDR36 to glaucoma is less understood. In the French-Canadian CA family, the MYOCK423E mutation causes wide phenotypic variability of autosomal dominant glaucoma. We recently detected in the pedigree, several clusters distinct for age-at-onset (AAO) supporting the presence of at least 1 modifier gene which alters glaucoma expressivity. To assess if WDR36 was a modifier gene, we performed genotype/phenotype correlation studies in double variants carrying MYOCK423E plus 1 WDR36 variation.

Methods: : Within the 709 members of the CA family, we reexamined the heterozygotes, affected or not. Newly recruited subjects were screened for MYOCK423E. 156 MYOCK423E heterozygotes were detected. Complete ophthalmologic records, some going back to the 1950s, were analyzed for 142 carriers; all of them were screened for WDR36 variations by sequencing.

Results: : 95 carriers were diagnosed juvenile or adult-onset open-angle glaucoma, or ocular hypertension (OHT) with Rx; 19 OHT without Rx; while 28 were still asymptomatic. Penetrance was 78% in carriers 40 years old or older. Since OHT occured before optic nerve degeneration, AAO was defined as age at which OHT or POAG was first detected. AAO varied from 7 to 63 years old. Among the variations detected in WDR36, 6 were non-synonymous amino acid (AA) changes. After excluding I264V polymorphic subjects, 24 MYOCK423E heterozygotes were double variants as they carried 1 WDR36 AA change. To assess for an effect of WDR36 variations on AAO, we compared AAO of glaucoma in these double variants versus the median of AAO in MYOCK423E carriers who were WDR36wild-type and shared a kinship coefficient of ≥ 0,0625 with the double variants; ie MYOC heterozygotes, 1st degree cousin or closer, in the neighborhood of the double variants. 18 double variants were analyzed, 10 of these showed AAO younger than the median AAO of their neighborhood. Five others displayed a younger AAO, but their respective AAO was within the range of their median AAO. Interestingly, 4 double variants, all of them with the WDR36D658G variation, were diagnosed > 10 years younger than their median AAO.

Conclusions: : WDR36 may contribute to the glaucoma phenotype as a modifier gene. Alternatively, a 2nd gene or locus, in linkage disequilibrium with WDR36, may act as a modifier of glaucoma severity in myocilin mutation carriers.

Keywords: gene modifiers • trabecular meshwork • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×